1. Home
  2. FTK vs RGNX Comparison

FTK vs RGNX Comparison

Compare FTK & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTK
  • RGNX
  • Stock Information
  • Founded
  • FTK 1985
  • RGNX 2008
  • Country
  • FTK United States
  • RGNX United States
  • Employees
  • FTK N/A
  • RGNX N/A
  • Industry
  • FTK Major Chemicals
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FTK Industrials
  • RGNX Health Care
  • Exchange
  • FTK Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • FTK 473.8M
  • RGNX 551.6M
  • IPO Year
  • FTK N/A
  • RGNX 2015
  • Fundamental
  • Price
  • FTK $15.35
  • RGNX $12.63
  • Analyst Decision
  • FTK Buy
  • RGNX Strong Buy
  • Analyst Count
  • FTK 2
  • RGNX 8
  • Target Price
  • FTK $12.00
  • RGNX $28.50
  • AVG Volume (30 Days)
  • FTK 451.2K
  • RGNX 642.0K
  • Earning Date
  • FTK 11-04-2025
  • RGNX 11-05-2025
  • Dividend Yield
  • FTK N/A
  • RGNX N/A
  • EPS Growth
  • FTK 82.12
  • RGNX N/A
  • EPS
  • FTK 0.43
  • RGNX N/A
  • Revenue
  • FTK $214,211,000.00
  • RGNX $155,782,000.00
  • Revenue This Year
  • FTK $19.47
  • RGNX $203.79
  • Revenue Next Year
  • FTK $11.22
  • RGNX $0.72
  • P/E Ratio
  • FTK $34.10
  • RGNX N/A
  • Revenue Growth
  • FTK 21.72
  • RGNX 74.95
  • 52 Week Low
  • FTK $4.70
  • RGNX $5.04
  • 52 Week High
  • FTK $17.93
  • RGNX $12.99
  • Technical
  • Relative Strength Index (RSI)
  • FTK 54.94
  • RGNX 65.71
  • Support Level
  • FTK $14.57
  • RGNX $11.50
  • Resistance Level
  • FTK $16.24
  • RGNX $12.99
  • Average True Range (ATR)
  • FTK 1.15
  • RGNX 0.78
  • MACD
  • FTK -0.17
  • RGNX 0.13
  • Stochastic Oscillator
  • FTK 28.77
  • RGNX 89.58

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: